(1) in the heading, by striking ‘‘, OBJECTIVES,
AND PRIORITIES’’ and inserting ‘‘AND PERFORM-
ANCE MEASURES’’;
(2) in the matter after the heading, by inserting
‘‘(1)’’ before ‘‘Each National Drug Control Strat-
egy’’;
(3) by redesignating paragraphs (1) through
(6) as subparagraphs (A) through (F);
(4) in subparagraph (A) (as redesignated by
paragraph (3)), by striking ‘‘and priorities’’ and in-
serting ‘‘and performance measures’’;
(5) in subparagraph (C) (as redesignated by
paragraph (3)), by striking ‘‘3-year projections’’ and
inserting ‘‘4-year projections’’; and
(6) by adding at the end the following new
paragraph:
‘‘(2) In establishing the performance measures re-
quired by this subsection, the Director shall—
‘‘(A) establish performance measures and tar-
gets expressed in terms of precise percentages for
each National Drug Control Strategy goal and objec-
tive;
‘‘(B) revise such performance measures and
targets as necessary, and reflect such performance
measures and targets in the National Drug Control
Program budget submitted to Congress;
‘‘(C) consult with affected National Drug Con-
trol Program agencies;
‘‘(D) identify programs and activities of Na-
tional Drug Control Program agencies that support
the goals of the National Drug Control Strategy;
‘‘(E) evaluate in detail the implementation by
each National Drug Control Program agency of pro-
gram activities supporting the National Drug Con-
trol Strategy;
‘‘(F) monitor consistency between the drug-re-
lated goals of the National Drug Control Program
agencies and ensure that drug control agency goals
and budgets fully support, and are fully consistent
with, the National Drug Control Strategy;
‘‘(G) coordinate the development and implemen-
tation of national drug control data collection and
reporting systems to support Federal policy formula-
tion and performance measurement;
‘‘(H) ensure that no Federal drug control funds
are expended for any study or contract relating to
the legalization (for a medical use or any other use)
of a substance listed in schedule I of section 202 of
the Controlled Substances Act (21 U.S.C. 812); and
‘‘(I) ensure that no Federal funds appropriated
for the High Intensity Drug Trafficking Program
are expended for the expansion of drug treatment
programs.’’.
SEC. 6. REPORT ON DESIGNATION OF HIGH INTENSITY
DRUG TRAFFICKING AREAS.
Section 1005(c)(3) is amended to read as follows:
‘‘(3) Not later than March 1 of each year, the Direc-
tor shall submit to Congress a report—
‘‘(A) on the effectiveness of, and need for, the
designation of areas under this subsection as high
intensity drug trafficking areas; and
‘‘(B) that includes any recommendations of the
Director for legislative action with respect to such
designation.’’.
SEC. 7. REPROGRAMMING AND TRANSFER OF FUNDS.
(a) EXPANSION OF TRANSFER AUTHORITY.—Section
1003(d)(8) (21 U.S.C. 1502(d)(8)) is amended to read as
follows:
‘‘(8) except to the extent that the Director’s au-
thority under this paragraph is limited in an annual
appropriations Act, and with the concurrence of the
head of the affected agency and upon advance ap-
proval of the Committees on Appropriations and the
authorizing committees of the House of Representa-
tives and the Senate, transfer funds appropriated to
a National Drug Control Program agency program,
activity, or function designated by the Director pur-
suant to subsection (c) to a different National Drug
Control Program agency program, activity, or func-
tion designated by the Director pursuant to such
subsection in an amount that does not exceed 5 per-
cent of the amount appropriated to either program,
activity, or function;’’.
(b) 
REPORT.—Section 
1003(c)(7) 
(21 
U.S.C.
1502(c)(7)) is amended to read as follows:
‘‘(7)(A) The Director shall report to Congress on a
quarterly basis (beginning with the first quarter of 1998)
on—
‘‘(i) the need for any reprogramming or trans-
fer of funds appropriated for National Drug Control
Program activities; and
‘‘(ii) any funds appropriated for National Drug
Control Program activities that were reprogrammed
or transferred during the quarter covered by the re-
port.
‘‘(B) The Director shall report to Congress as re-
quired by paragraph (A) not later than 30 days after the
last day of each applicable quarter.’’.
SEC. 8. LONG-TERM PLAN FOR REDUCTION OF DRUG USE.
Section 1003 (21 U.S.C. 1502) is amended by adding
at the end the following new subsection:
‘‘(g) LONG-TERM PLAN FOR REDUCTION OF DRUG
USE.—Not later than March 1, 1998, the Director shall
submit to Congress a long-term plan for reducing the pop-
ulation of illegal drug users in the United States by De-
cember 31, 2001, to 3 percent of the population of the
United States or less. Such plan shall include—
‘‘(1) a request for funds and other resources
necessary to achieve such reduction within the guide-
lines of the balanced budget agreement of 1997; and
‘‘(2) the justifications for each such request.’’.
SEC. 9. DRUG POLICY COUNCIL.
The National Narcotics Leadership Act of 1988 (21
U.S.C. 1501 et seq.) is further amended by adding at the
end of chapter 1 the following new section:
‘‘SEC. 1013. DRUG POLICY COUNCIL.
‘‘(a) ESTABLISHMENT.—There is established in the
Executive Office of the President a Drug Policy Council,
which shall be composed of the members of the President’s
cabinet, and the purpose of which shall be to make cabi-
net-level decisions regarding national drug policy.
‘‘(b) CHAIRMAN.—The President shall be the Chair-
man of the Drug Policy Council established by subsection
(a).
‘‘(c) EXECUTIVE DIRECTOR.—The Director of the
Office of National Drug Control Policy shall be the Execu-
tive Director of the Drug Policy Council established by
subsection (a).’’.
SEC. 10. DEFINITION OF NATIONAL DRUG CONTROL PRO-
GRAM AGENCY.
Section 1010(6) (21 U.S.C. 1507(6)) is amended to
read as follows:
‘‘(6) the term ‘National Drug Control Program
agency’ means any agency that is responsible for im-
plementing any aspect of the National Drug Control
Strategy, including any agency that receives Federal
funds to implement any aspect of the National Drug
Control Strategy;’’.
SEC. 11. EXTENSION OF DATE FOR TERMINATION OF OF-
FICE OF NATIONAL DRUG CONTROL POLICY.
Section 1009 is amended by striking ‘‘September 30,
1997’’ and inserting ‘‘September 30, 1999’’.
SEC. 12. EXTENSION OF AUTHORIZATION OF APPROPRIA-
TIONS.
Section 1011 is amended by striking ‘‘8 succeeding
fiscal years’’ and inserting ‘‘10 succeeding fiscal years’’.
SEC. 13. REPORT REQUIRED.
Not later than November 1, 1997, the Director of the
Office of National Drug Control Policy shall submit to
Congress a report including—
(1) proposed goals, targets, performance meas-
ures (as described in section 1003(b)(1) of the Na-
tional Narcotics Leadership Act of 1998 (21 U.S.C.
1502(b)(1)), and specific initiatives with respect to
the National Drug Control Program, including the
High Intensity Drug Trafficking Area Program; and
(2) proposals to coordinate the efforts of all
National Drug Control Program agencies.
SEC. 14. APPOINTMENT OF TEMPORARY ADMINISTRATOR
FOR 
DRUG-FREE 
COMMUNITIES 
SUPPORT
PROGRAM.
(a) IN
GENERAL.—Section 1031(c) (21 U.S.C.
1531(c)) is amended—
(1) by inserting ‘‘(1)’’ after ‘‘(c) ADMINISTRA-
TION.—’’; and
(2) by adding at the end the following new
paragraph:
‘‘(2) The Director shall appoint an individual to act
as Administrator until such time as an individual is ap-
pointed to such position under paragraph (1).’’.
(b) DEADLINE FOR APPOINTMENT.—The Director of
the Office of National Drug Control Policy shall appoint
an individual to act as Administrator of the Drug-Free
Communities Support Program under section 1031(c)(2)
of the National Narcotics Leadership Act of 1988 (as
added by subsection (a)) not later than 30 days after the
date of the enactment of this Act.
SEC. 15. CONSISTENCY WITH NATIONAL SECURITY ACT OF
1947.
Section 1004 (21 U.S.C. 1503) is amended—
(1) in subsection (a)—
(A) by striking ‘‘(1)’’;
(B) by striking ‘‘(2)(A)’’ and inserting
‘‘(b) CONSISTENCY WITH NATIONAL SECURITY
ACT OF 1947.—(1)’’;
(C) by striking ‘‘(B)’’ and inserting ‘‘(2)’’;
and
(D) by striking ‘‘subparagraph (A)’’ and
inserting ‘‘paragraph (1)’’; and
(2) by redesignating subsections (b) and (c) as
subsections (c) and (d) respectively.
Passed the House of Representatives October 21,
1997.
Attest:
Clerk.